EUVIMEDEUVIMED entdecken
Crossref

Identification of Dalbergiae Odoriferae Lignum active ingredients and potential mechanisms in the treatment of adriamycin-induced cardiotoxicity based on network pharmacology and experimental verification

Yuling Luan, Xinyue Ding, Lingxiao Zhang, Shuyan Huang, Chenghao Yang, Yueer Tang, Lina Xing, Hui Zhang, Zongjun Liu

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024

DOI: 10.1007/s00210-024-03016-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2024. Verfasst von Yuling Luan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Translational Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 164 Lanxi Road, Putuo Di…. Hauptthemen laut MEDLINE: Doxorubicin, Dalbergia, Molecular Docking Simulation, Network Pharmacology. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Clinical Advantage Discipline of Health System of Putuo District in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The purpose of this study is to investigate the ingredients and mechanisms through which Dalbergiae Odoriferae Lignum (DOL) reduces adriamycin-induced cardiotoxicity. DOL's ingredients and drug targets were acquired from Traditional Chinese Medicine System Pharmacology Database and Analysis Platform (TCMSP), and adriamycin-induced cardiotoxicity disease targets were gathered from GeneCards and National Center for Biotechnology Information (NCBI). The therapeutic targets of DOL against adriamycin-induced cardiotoxicity were identified by intersecting drug and disease targets. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) were conducted using R. Subsequently, core targets were determined and used for molecular docking with DOL ingredients. In vitro and in vivo experiments validated DOL's primary ingredients against adriamycin-induced cardiotoxicity efficacy. Western blot and immunohistochemistry verified its impact on target protein. After intersecting 530 drug targets and 51 disease targets, 19 therapeutic targets for DOL alleviated adriamycin-induced cardiotoxicity were received. Molecular docking demonstrated that DOL primary ingredient formononetin had a robust binding affinity for nitric oxide synthase 3 (NOS3). Experimental results showed that formononetin effectively mitigated adriamycin-induced cardiotoxicity. Additionally, western blot and immunohistochemistry showed that formononetin improved NOS3 expression. The network pharmacology and experimentation suggest that the primary ingredient of DOL, formononetin, may target NOS3 to act as a therapeutic agent for adriamycin-induced cardiotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinDalbergiaMolecular Docking SimulationNetwork PharmacologyCardiotoxicityDrugs, Chinese HerbalAnimalsMaleIsoflavonesNitric Oxide Synthase Type IIIMiceMyocytes, CardiacAntibiotics, AntineoplasticRats, Sprague-Dawley

Stichwörter der Autor:innen

Adriamycin-induced cardiotoxicityDalbergiae Odoriferae LignumExperimental validationFormononetinMolecular dockingNetwork pharmacology

Substanzen

DoxorubicinDrugs, Chinese HerbalIsoflavonesNitric Oxide Synthase Type IIIformononetinAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Institute of Cardiovascular Translational Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 164 Lanxi Road, Putuo District, Shanghai, China.
  • Institute of Cardiovascular Translational Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 164 Lanxi Road, Putuo District, Shanghai, China. bijibenzh@163.com.
  • Institute of Cardiovascular Translational Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 164 Lanxi Road, Putuo District, Shanghai, China. liuzongjun1548@shutcm.edu.cn.

Förderung

  • Clinical Advantage Discipline of Health System of Putuo District in Shanghai

Zitieren

APA

Luan, Y., Ding, X., Zhang, L., Huang, S., Yang, C., Tang, Y., Xing, L., Zhang, H., & Liu, Z. (2024). Identification of Dalbergiae Odoriferae Lignum active ingredients and potential mechanisms in the treatment of adriamycin-induced cardiotoxicity based on network pharmacology and experimental verification. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-024-03016-8

Vancouver

Luan Y, Ding X, Zhang L, Huang S, Yang C, Tang Y, et al. Identification of Dalbergiae Odoriferae Lignum active ingredients and potential mechanisms in the treatment of adriamycin-induced cardiotoxicity based on network pharmacology and experimental verification. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. doi:10.1007/s00210-024-03016-8

BibTeX
@article{Luan2024,
  author = {Luan, Yuling and Ding, Xinyue and Zhang, Lingxiao and Huang, Shuyan and Yang, Chenghao and Tang, Yueer and Xing, Lina and Zhang, Hui and Liu, Zongjun},
  title = {Identification of Dalbergiae Odoriferae Lignum active ingredients and potential mechanisms in the treatment of adriamycin-induced cardiotoxicity based on network pharmacology and experimental verification},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  doi = {10.1007/s00210-024-03016-8}
}
Kostenlos starten →